Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation
- 8 November 2002
- journal article
- Published by Elsevier
- Vol. 25 (3) , 217-225
- https://doi.org/10.1016/0168-3659(93)90080-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lysozyme degradation of partially deacetylated chitin, its films and hydrogelsPublished by Elsevier ,2003
- Cross-linked Chitosan Microspheres: Preparation and Evaluation as a Matrix for the Controlled Release of PharmaceuticalsJournal of Pharmacy and Pharmacology, 1992
- Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, OxantrazolePharmaceutical Research, 1992
- Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosansInternational Journal of Pharmaceutics, 1991
- Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Investigation of Prolonged Drug Release from Matrix Formulations of ChitosanDrug Development and Industrial Pharmacy, 1990
- Preparation and Evaluation Of Drug-Containing Chitosan BeadsDrug Development and Industrial Pharmacy, 1989
- Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin or chitosan.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982